Amgen (AMGN) Earnings Date, Estimates & Call Transcripts

$320.56

-3.80 (-1.17%)

(As of 09/6/2024 08:48 PM ET)

Upcoming Earnings Date: Oct. 29Estimated
Actual EPS (Aug. 6): $4.97 Missed By -$0.04
Consensus EPS (Aug. 6): $5.01

AMGN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AMGN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad Porter & Company

Trump’s weapon lurks in abandoned America

Unemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. Hopelessness abounds. And looking in, the future here looks bleak for these forgotten souls. But in a strange twist of fate, something miraculous is taking place…

Go here now to watch my new documentary

Amgen Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2024	4	$3.64	$4.86	$4.10
Q2 2024	4	$4.85	$5.14	$5.04
Q3 2024	4	$4.83	$5.23	$5.03
Q4 2024	4	$4.81	$5.48	$5.21
FY 2024	16	$18.13	$20.71	$19.37
Q1 2025	2	$4.79	$4.88	$4.84
Q2 2025	2	$5.11	$5.37	$5.24
Q3 2025	2	$5.18	$5.34	$5.26
Q4 2025	2	$4.33	$5.43	$4.88
FY 2025	8	$19.41	$21.02	$20.22
Q1 2026	1	$4.86	$4.86	$4.86
Q2 2026	1	$5.23	$5.23	$5.23

AMGN Earnings Date and Information

Amgen last announced its quarterly earnings data on August 6th, 2024. The medical research company reported $4.97 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $5.01 by $0.04. The company earned $8.39 billion during the quarter, compared to the consensus estimate of $8.35 billion. Its quarterly revenue was up 20.1% on a year-over-year basis. Amgen has generated $7.00 earnings per share over the last year ($7.00 diluted earnings per share) and currently has a price-to-earnings ratio of 45.8. Earnings for Amgen are expected to grow by 5.28% in the coming year, from $19.49 to $20.52 per share. Amgen has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, October 29th, 2024 based off prior year's report dates.

Amgen Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
10/29/2024 (Estimated)	-	-	-	-	-	-	-
8/6/2024	Q2 2024	$5.01	$4.97	($0.04)	$8.56	$8.35 billion	$8.39 billion
5/2/2024	Q1 2024	$3.76	$3.96	+$0.20	$8.13	$7.45 billion	$7.45 billion
2/6/2024	Q4 2023	$4.66	$4.71	+$0.05	$8.00	$8.13 billion	$8.20 billion
10/31/2023	Q3 2023	$4.65	$4.96	+$0.31	$6.70	$6.92 billion	$6.90 billion
8/3/2023	Q2 2023	$4.44	$5.00	+$0.56	$7.43	$6.66 billion	$7.00 billion
4/27/2023	Q1 2023	$3.84	$3.98	+$0.14	$2.68	$6.18 billion	$6.11 billion
Get the Latest News and Ratings for AMGN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Amgen and its competitors with MarketBeat's FREE daily newsletter.
2/7/2023	Q4 2022	$4.04	$4.09	+$0.05	$5.18	$6.77 billion	$6.84 billion
11/3/2022	Q3 2022	$4.43	$4.70	+$0.27	$5.42	$6.56 billion	$6.65 billion
8/4/2022	Q2 2022	$4.40	$4.65	+$0.25	$6.85	$6.53 billion	$6.59 billion
4/27/2022	Q1 2022	$4.22	$4.25	+$0.03	$5.82	$6.09 billion	$6.24 billion
2/7/2022	Q4 2021	$4.14	$4.36	+$0.22	$5.36	$6.87 billion	$6.85 billion
11/2/2021	Q3 2021	$4.22	$4.67	+$0.45	$6.03	$6.70 billion	$6.71 billion
8/2/2021	Q2 2021	$4.09	$4.38	+$0.29	$7.95	$6.43 billion	$6.53 billion
4/26/2021	Q1 2021	$4.05	$3.70	($0.35)	$4.57	$6.30 billion	$5.90 billion
2/1/2021	Q4 2020	$3.39	$3.81	+$0.42	$4.86	$6.57 billion	$6.63 billion
11/2/2020	Q3 2020	$3.75	$4.37	+$0.62	$5.31	$6.38 billion	$6.42 billion
7/28/2020	Q2 2020	$3.81	$4.25	+$0.44	$5.45	$6.19 billion	$6.21 billion
4/30/2020	Q1 2020	$3.70	$4.17	+$0.47	$5.27	$6.01 billion	$6.16 billion
1/30/2020	Q4 2019	$3.47	$3.64	+$0.17	$4.43	$6.04 billion	$6.20 billion
10/29/2019	Q3 2019	$3.53	$3.66	+$0.13	$4.05	$5.63 billion	$5.74 billion

Amgen Earnings - Frequently Asked Questions

When is Amgen's earnings date?: Amgen has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, October 29th, 2024 based off last year's report dates. Learn more on AMGN's earnings history.
What guidance has Amgen issued on next quarter's earnings?: Amgen issued an update on its FY 2024 earnings guidance on Tuesday, August, 6th. The company provided earnings per share guidance of 19.100-20.100 for the period, compared to the consensus EPS estimate of 17.870. The company issued revenue guidance of $32.8 billion-$33.8 billion, compared to the consensus revenue estimate of $30.3 billion.
Did Amgen beat their earnings estimates last quarter?: In the previous quarter, Amgen (NASDAQ:AMGN) missed the analysts' consensus estimate of $5.01 by $0.04 with a reported earnings per share (EPS) of $4.97. Learn more on analysts' earnings estimate vs. AMGN's actual earnings.
How can I listen to Amgen's earnings conference call?: The conference call for Amgen's latest earnings report can be listened to online. Listen to Conference Call
How can I read Amgen's conference call transcript?: The conference call transcript for Amgen's latest earnings report can be read online. Read Transcript
How much revenue does Amgen generate each year?: Amgen (NASDAQ:AMGN) has a recorded annual revenue of $30.93 billion.
How much profit does Amgen generate each year?: Amgen (NASDAQ:AMGN) has a recorded net income of $6.72 billion. AMGN has generated $7.00 earnings per share over the last four quarters.
What is Amgen's price-to-earnings ratio?: Amgen (NASDAQ:AMGN) has a trailing price-to-earnings ratio of 45.79 and a forward price-to-earnings ratio of 16.45. The price/earnings-to-growth ratio is 2.96.
What is Amgen's EPS forecast for next year?: Amgen's earnings are expected to grow from $19.49 per share to $20.52 per share in the next year, which is a 5.28% increase.